ATE221533T1 - Verfahren zur racematspaltung von etodolac unter verwendung von glucamin-derivaten - Google Patents

Verfahren zur racematspaltung von etodolac unter verwendung von glucamin-derivaten

Info

Publication number
ATE221533T1
ATE221533T1 AT95915264T AT95915264T ATE221533T1 AT E221533 T1 ATE221533 T1 AT E221533T1 AT 95915264 T AT95915264 T AT 95915264T AT 95915264 T AT95915264 T AT 95915264T AT E221533 T1 ATE221533 T1 AT E221533T1
Authority
AT
Austria
Prior art keywords
etodolac
pct
glucamine
racemat
classification
Prior art date
Application number
AT95915264T
Other languages
English (en)
Inventor
Brian Michael Adger
Ulrich Conrad Dyer
Martin Woods
John Francis Paul Andrews
Helen Frances Baker
Road Milton
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9407225A external-priority patent/GB9407225D0/en
Priority claimed from GBGB9501455.1A external-priority patent/GB9501455D0/en
Application filed by Arakis Ltd filed Critical Arakis Ltd
Application granted granted Critical
Publication of ATE221533T1 publication Critical patent/ATE221533T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95915264T 1994-04-12 1995-04-11 Verfahren zur racematspaltung von etodolac unter verwendung von glucamin-derivaten ATE221533T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9407225A GB9407225D0 (en) 1994-04-12 1994-04-12 Chiroscience limited
GBGB9501455.1A GB9501455D0 (en) 1995-01-25 1995-01-25 Analgesic agent and its use
PCT/GB1995/000857 WO1995027713A1 (en) 1994-04-12 1995-04-11 Process for the resolution of etodolac using glucamine derivatives

Publications (1)

Publication Number Publication Date
ATE221533T1 true ATE221533T1 (de) 2002-08-15

Family

ID=26304688

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95915264T ATE221533T1 (de) 1994-04-12 1995-04-11 Verfahren zur racematspaltung von etodolac unter verwendung von glucamin-derivaten

Country Status (9)

Country Link
US (1) US5811558A (de)
EP (1) EP0755398B1 (de)
JP (1) JPH09511516A (de)
AT (1) ATE221533T1 (de)
AU (1) AU2220695A (de)
DE (1) DE69527617T2 (de)
ES (1) ES2177644T3 (de)
NO (1) NO964346L (de)
WO (1) WO1995027713A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574183A (en) * 1995-01-24 1996-11-12 Albemarle Corporation Preparation of optically active aliphatic carboxylic acids
US6399093B1 (en) 1999-05-19 2002-06-04 Advanced Medical Instruments Method and composition to treat musculoskeletal disorders
US7129262B2 (en) * 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7151100B1 (en) 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7361680B2 (en) * 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US6545034B1 (en) 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
GB0007239D0 (en) * 2000-03-24 2000-05-17 Nycomed Imaging As Use
US20040152672A1 (en) * 2000-08-09 2004-08-05 Carson Dennis A. Indole compounds useful for the treatment of cancer
US7601846B2 (en) * 2001-06-26 2009-10-13 The Regents Of The University Of California Compounds having activity as inhibitors of apoptosis
US20030232794A1 (en) * 2001-06-26 2003-12-18 Cottam Howard B. Use of STAT-6 inhibitors as therapeutic agents
GB0206505D0 (en) * 2002-03-19 2002-05-01 Euro Celtique Sa Pharmaceutical combination
WO2004026116A2 (en) * 2002-09-19 2004-04-01 The Regents Of The University Of California Use of etodoclac to treat hyperplasia
ITMI20031471A1 (it) 2003-07-18 2005-01-19 Chemi Spa Processo per la racemizzazione dell'acido etodolico
ES2901955T3 (es) 2004-10-08 2022-03-24 Abbvie Inc Sal meglumínica y formas cristalinas de la misma de un farmaco (delafloxacina)
ATE549016T1 (de) * 2005-04-11 2012-03-15 Abbott Lab Pharmazeutische zusammensetzungen mit verbesserten auflöseprofilen für schwerlösliche wirkstoffe
ITMI20060894A1 (it) 2006-05-05 2007-11-06 Univ Catania Ciclodestrine funzionalizzate con etodolac come agenti di rilascio sito specifico
EP2029597A4 (de) 2006-05-31 2011-11-23 Univ California Purinanaloga
CN102850204B (zh) * 2011-06-29 2015-08-19 徐州医学院 一种(s)-2-芳基丙酸类非甾体抗炎药的拆分方法
WO2013169218A1 (en) 2012-05-08 2013-11-14 Mahmut Bilgic Pharmaceutical compositions of s-etodolac

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501899A (en) * 1983-08-16 1985-02-26 American Home Products Corporation Resolution of (+)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cholesteryl aniline
US4520203A (en) * 1983-08-16 1985-05-28 American Home Products Corporation Resolution of (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cinchonine
US4544757A (en) * 1984-02-16 1985-10-01 American Home Products Corporation Process for the resolution of pyrano[3,4-b]indole-1-acetic acids
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5256293A (en) * 1991-09-20 1993-10-26 Research Corporation Technologies, Inc. Separation of enantiomers of non-steroidal anti-inflammatory drugs and chiral selector therefor

Also Published As

Publication number Publication date
AU2220695A (en) 1995-10-30
ES2177644T3 (es) 2002-12-16
JPH09511516A (ja) 1997-11-18
WO1995027713A1 (en) 1995-10-19
EP0755398A1 (de) 1997-01-29
EP0755398B1 (de) 2002-07-31
NO964346D0 (no) 1996-10-11
US5811558A (en) 1998-09-22
DE69527617T2 (de) 2003-04-10
DE69527617D1 (de) 2002-09-05
NO964346L (no) 1996-12-11

Similar Documents

Publication Publication Date Title
DE69527617D1 (de) Verfahren zur racematspaltung von etodolac unter verwendung von glucamin-derivaten
DE59209643D1 (de) Verfahren zur trennung von 5-methyl-tetrahydrofolsäure
ATE160352T1 (de) Verfahren zur herstellung von amino-1-hydroxy- alkyliden-1,1-bisphosphonsäuren
DE59606209D1 (de) Verfahren und Vorrichtung zur kontinuierlichen Herstellung von Alkylestern der (Meth)acrylsäure
DE69525950D1 (de) Racemisierungsverfahren bei der herstellung von levobupivacaine und analogen
DE69003944D1 (de) Verfahren zur gesteuerten anaeroben zersetzung von abfall.
DE69635320D1 (de) Verfahren zur Herstellung von Schmierölen
HUT77631A (hu) Eljárás a levobupivakain és származékai rezolválására
DE69616856D1 (de) Verfahren zur Herstellung von optisch aktiven Alkoholen und von optischen aktiven Aminen
ATE212380T1 (de) Verfahren zur herstellung von nikotinsäureamid
ATE187957T1 (de) Verfahren zur hydrierung von iminen
DE59611017D1 (de) Verfahren zur herstellung von n-substituierten 3-hydroxypyrazolen
DE59604295D1 (de) Verfahren zur Racematspaltung von Tramadol
ATE216365T1 (de) Verfahren zur racematspaltung
ATE257142T1 (de) Verfahren zur racematspaltung von 2- hydroxypropionsäuren
DE69403571D1 (de) Verfahren zur Herstellung von Acrylamid
DE69107410D1 (de) Verfahren zur Herstellung von optischen aktiven Aminen.
DE59104247D1 (de) Verfahren zur Racemisierung von optisch aktiven 1-Aryl-alkylaminen.
DE69622692D1 (de) Verfahren zur herstellung von ungesättigten nitrilen
DE69607113D1 (de) Verfahren zur Racemisierung von optisch aktiven 1-Phenylethylamin-Derivaten
ATE227725T1 (de) Verfahren zur herstellung von galanthanin
ATE132535T1 (de) Verfahren zur diskontinuierlichen herstellung von l-carnitin auf mikrobiologischem weg
DE69713163D1 (de) Verfahren zur herstellung von enantiomerisch angereicherten n-acylazetidin-2-carbonsäuren
DE3881664D1 (de) Verfahren zur herstellung von acrylamid.
DE58902228D1 (de) Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties